Cardiovascular Systems () EBITDA US GAAP (year values)

2020 2021 2022 2022   LTM ?
EBITDA, bln rub ? -25.5 -10.7 -31.6 -34.5   -26.4
Changes by years, y/y, % +2 996% -58% -100% +9%    

Cardiovascular Systems. EBITDA US GAAP, bln rub

Cardiovascular Systems. EBITDA US GAAP, changes, %

Cardiovascular Systems. EBITDA US GAAP, sum by quarters, bln rub

Cardiovascular Systems () EBITDA US GAAP (quarter values)

2022Q4 2022Q4 2023Q1 2023Q1 2023Q2   LTM ?
EBITDA, bln rub ? -0.008 -9.14 -0.009 -9.02 -8.18   -26.4
Changes by years, y/y, % -100% +151% -100% -6%    
Changes by quarters, q/q, % -100% +108 131% -100% +95 982% -9%    

Cardiovascular Systems. EBITDA US GAAP, bln rub

Cardiovascular Systems. EBITDA US GAAP, changes, y/y, %

Cardiovascular Systems. EBITDA US GAAP, changes, q/q, %